Overview
Giant keratoacanthoma (GKA) is a rapidly growing, solitary skin lesion characterized by a dome-shaped nodule with a prominent central keratin plug, resembling squamous cell carcinoma clinically but histologically distinct. It typically presents as a large, well-demarcated lesion, often exceeding 2 cm in diameter, predominantly affecting sun-exposed areas of middle-aged to elderly individuals. The clinical significance lies in its potential for local tissue destruction and the diagnostic challenge it poses due to its resemblance to more aggressive malignancies. Early differentiation is crucial to avoid unnecessary aggressive treatments like extensive surgery or radiation therapy. Proper management is essential in day-to-day practice to prevent complications and ensure optimal cosmetic outcomes 23.Pathophysiology
The exact pathophysiology of giant keratoacanthomas remains incompletely understood, but it is generally considered a variant of keratoacanthoma, which is thought to arise from an aberrant wound healing response triggered by ultraviolet radiation or other forms of trauma. At the molecular level, there is evidence of hyperproliferation driven by aberrant activation of growth factor pathways, including epidermal growth factor receptor (EGFR) signaling 2. Cellular changes involve rapid keratinocyte proliferation in the epidermis, leading to the characteristic central crater filled with keratin. While the genetic alterations seen in squamous cell carcinoma are typically absent, chronic inflammation and immune dysregulation may play roles in sustaining the lesion's growth. The interplay between environmental factors, genetic predispositions, and cellular mechanisms contributes to the development and progression of GKA, highlighting the need for multifaceted therapeutic approaches 2.Epidemiology
Giant keratoacanthomas are relatively rare compared to other dermatological conditions, with incidence rates varying by geographic location and population characteristics. They predominantly affect older adults, with a median age of onset around 60 years, and show a slight male predominance. Sun-exposed areas, particularly the face and extremities, are most commonly involved. While precise global prevalence figures are lacking, sporadic case reports and small series suggest a higher incidence in regions with prolonged sun exposure and fair-skinned populations. Trends indicate no significant temporal increase, but awareness and reporting may improve with advancing dermatological education and imaging techniques 23.Clinical Presentation
Giant keratoacanthomas typically present as solitary, rapidly enlarging nodules with a firm consistency and a characteristic central keratin plug, often described as a "volcano-like" appearance. Patients may report a sudden onset of a lesion that grows quickly over weeks to months. Pain, tenderness, and bleeding from the central plug are common symptoms. Atypical presentations can include lesions in non-sun-exposed areas or atypical histological features, which may complicate diagnosis. Red-flag features include rapid growth, ulceration, and signs of systemic involvement, necessitating prompt referral for further evaluation to rule out malignancy 23.Diagnosis
The diagnosis of giant keratoacanthoma involves a combination of clinical assessment and histopathological examination. Clinically, the lesion's rapid growth, central keratin plug, and well-demarcated borders are key indicators. Definitive diagnosis relies on biopsy and histopathology, where characteristic features include full-thickness epidermal proliferation with a hyperkeratotic plug and a well-defined granular layer. Specific criteria for diagnosis include:Management
First-Line Treatment
Excision with Skin Grafting:Second-Line Treatment
Intralesional Corticosteroids:Adjuvant Radiotherapy:
Refractory Cases / Specialist Escalation
Combination Therapy:Complications
Common complications of giant keratoacanthomas include:Prognosis & Follow-up
The prognosis for giant keratoacanthomas is generally favorable with appropriate treatment, but recurrence remains a concern, especially in larger or incompletely excised lesions. Prognostic indicators include lesion size, completeness of excision, and adherence to follow-up protocols. Recommended follow-up intervals typically involve:Special Populations
Pediatrics
Giant keratoacanthomas are exceedingly rare in pediatric populations, but when encountered, they require careful management to avoid unnecessary aggressive treatments. Conservative approaches like intralesional corticosteroids may be preferred initially.Elderly Patients
Elderly patients often present with larger, more symptomatic lesions due to prolonged sun exposure. Management should focus on minimizing complications and ensuring adequate pain control and wound care post-procedure.Comorbidities
Patients with chronic skin conditions or immunosuppression may have a higher risk of recurrence or atypical presentations, necessitating closer monitoring and possibly more aggressive initial treatments 23.Key Recommendations
References
1 Yeh HY, Tu CW, Chen YJ, Cheng WP, Shih PY, Yu CC et al.. Disease outbreaks substantially enhance greenhouse gas emissions from Asian seabass (Lates calcarifer) aquaculture pond. Marine pollution bulletin 2026. link 2 Masoodi Z, Ahmad I, Khurram MF, Haq A. Excision, skin grafting, corticosteroids, adjuvant radiotherapy, pressure therapy, and emancipation: the ESCAPE model for successful taming of giant auricular keloids. Advances in skin & wound care 2014. link 3 Osswald SS, Elston DM, Vogel PS. Giant right plantar keloid treated with excision and tissue-engineered allograft. Journal of the American Academy of Dermatology 2003. link 4 Vale RD, Schnapp BJ, Reese TS, Sheetz MP. Organelle, bead, and microtubule translocations promoted by soluble factors from the squid giant axon. Cell 1985. link90204-1) 5 Armstrong CM. Time course of TEA(+)-induced anomalous rectification in squid giant axons. The Journal of general physiology 1966. link